Neoehrlichia mikurensis —An emerging opportunistic tick‐borne infection in immunosuppressed patients
Journal of Internal Medicine · 2023
DOI: 10.1111/joim.13638 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Internal Medicine, 2023. Verfasst von Rosa M M Gynthersen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Anaplasmataceae Infections, Anaplasmataceae, Tick-Borne Diseases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Neoehrlichia mikurensis ( N. mikurensis ) is a newly discovered tick‐borne pathogen that can inflict life‐threatening illness in immunocompromised patients. N. mikurensis infection is only detectable by polymerase chain reaction (PCR)‐based methodologies. We describe three distinct clinical manifestations of N. mikurensis infection (neoehrlichiosis) in Danish patients receiving B‐lymphocyte‐depleting therapy, rituximab, for underlying hematological, rheumatological, or neurological disorders. All three patients went through a protracted pre‐diagnostic period.
Methods
N. mikurensis DNA was detected and confirmed using two methods. Blood was tested by specific real‐time PCR targeting the groEL gene and by 16S and 18S profiling followed by sequencing. Bone marrow was analyzed by 16S and 18S profiling.
Results
N. mikurensis was detected in blood samples in all three cases and in bone marrow from one of the three. The severity of the symptoms ranged from prolonged fever lasting more than 6 months to life‐threatening hyperinflammation in the form of hemophagocytic lymphohistiocytosis (HLH). Interestingly, all patients presented with splenomegaly and two with hepatomegaly. After starting doxycycline therapy, symptoms were relieved within a few days, and biochemistry and organomegaly quickly normalized.
Conclusion
We present three Danish patients recognized by the same clinician over a period of 6 months, strongly suggesting that many cases are going unrecognized. Second, we describe the first case of N. mikurensis ‐induced HLH and emphasize the potential severity of undetected neoehrlichiosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Laboratory of Parasitology, Department of Bacteria, Parasites, and Fungi, Statens Serum Institut, Copenhagen, Denmark.
- Department of Pathology, Herlev and Gentofte Hospital, Herlev, Denmark.
- Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Rosa M M Gynthersen, Daniel El Fassi
Zitieren
APA
Gynthersen, R. M. M., Stensvold, C. R., Nielsen, S. L., Møller, H. J., Nielsen, H. V., Lebech, A. M., Christensen, J. R., Mens, H., & El Fassi, D. (2023). Neoehrlichia mikurensis —An emerging opportunistic tick‐borne infection in immunosuppressed patients. Journal of Internal Medicine. https://doi.org/10.1111/joim.13638
Vancouver
Gynthersen RMM, Stensvold CR, Nielsen SL, Møller HJ, Nielsen HV, Lebech AM, et al. Neoehrlichia mikurensis —An emerging opportunistic tick‐borne infection in immunosuppressed patients. Journal of Internal Medicine. 2023. doi:10.1111/joim.13638
BibTeX
@article{Gynthersen2023,
author = {Gynthersen, Rosa M M and Stensvold, Christen Rune and Nielsen, Signe Ledou and Møller, Holger Jon and Nielsen, Henrik Vedel and Lebech, Anne-Mette and Christensen, Jeppe Romme and Mens, Helene and El Fassi, Daniel},
title = {Neoehrlichia mikurensis —An emerging opportunistic tick‐borne infection in immunosuppressed patients},
journal = {Journal of Internal Medicine},
year = {2023},
doi = {10.1111/joim.13638}
}
EUVIMED